{
    "2020-10-28": [
        [
            {
                "time": "",
                "original_text": "值 得 买 ( 3 0 0 7 8 5 ) ： 整 体 业 绩 维 持 高 增 长 期 待 Q 4 用 户 规 模 和 G M V 同 步 提 升",
                "features": {
                    "keywords": [
                        "整体业绩",
                        "高增长",
                        "Q4",
                        "用户规模",
                        "GMV"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "电商"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-06",
                "original_text": "华 熙 生 物 ( 6 8 8 3 6 3 . S H ) 4 5 2 6 . 6 3 万 股 限 售 股 将 于 1 1 月 6 日 起 上 市 流 通 解 禁",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "限售股",
                        "解禁",
                        "上市流通"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-06",
                "original_text": "华 熙 生 物 ： 4 5 2 6 万 股 限 售 股 1 1 月 6 日 上 市 流 通 解 禁",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "限售股",
                        "解禁",
                        "上市流通"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "简 评 | 值 得 买 ： 营 收 、 利 润 稳 定 增 长 ， 看 好 公 司 业 务 扩 张 、 营 销 推 广 带 来 月 活 用 户 及 业 绩 增 长 提 速 【 建 投 传 媒 互 联 网 】",
                "features": {
                    "keywords": [
                        "营收",
                        "利润",
                        "稳定增长",
                        "业务扩张",
                        "营销推广",
                        "月活用户",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "电商"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【 东 北 社 服 李 慧 / 李 森 蔓 / 徐 乔 威 】 社 服 2 0 2 1 年 投 资 策 略 ： 聚 焦 新 消 费 、 开 启 新 周 期",
                "features": {
                    "keywords": [
                        "社服",
                        "投资策略",
                        "新消费",
                        "新周期"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "服务业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "玻 尿 酸 ： 行 业 规 范 亟 待 解 决 ， 上 市 公 司 风 险 或 被 低 估",
                "features": {
                    "keywords": [
                        "玻尿酸",
                        "行业规范",
                        "上市公司风险",
                        "低估"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}